204 related articles for article (PubMed ID: 29961277)
21. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
[TBL] [Abstract][Full Text] [Related]
22. EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients.
Lu WG; Ye F; Shen YM; Fu YF; Chen HZ; Wan XY; Xie X
Int J Gynecol Cancer; 2008; 18(2):357-62. PubMed ID: 17711444
[TBL] [Abstract][Full Text] [Related]
23. Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine (FAEV): A report based on our 10-year clinical experiences.
Yang J; Xiang Y; Wan X; Feng F; Ren T
Gynecol Oncol; 2016 Oct; 143(1):68-72. PubMed ID: 27426306
[TBL] [Abstract][Full Text] [Related]
24. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.
Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y
Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520
[TBL] [Abstract][Full Text] [Related]
25. Reproductive outcomes after floxuridine-based regimens for gestational trophoblastic neoplasia: A retrospective cohort study in a national referral center in China.
Jiang F; Yang K; Wan XR; Xiang Y; Feng FZ; Ren T; Yang JJ; Zhao J
Gynecol Oncol; 2020 Nov; 159(2):464-469. PubMed ID: 32917411
[TBL] [Abstract][Full Text] [Related]
26. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
Braga A; de Souza Hartung Araújo C; Mora PAR; Paulino E; de Melo AC; Velarde GC; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
Gynecol Oncol; 2020 Mar; 156(3):598-605. PubMed ID: 31928806
[TBL] [Abstract][Full Text] [Related]
27. [Management and prognosis in stage IV gestational trophoblastic neoplasia patients].
Yang JJ; Xiang Y; Wan XR; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):693-6. PubMed ID: 17199926
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
[TBL] [Abstract][Full Text] [Related]
29. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
[TBL] [Abstract][Full Text] [Related]
30. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
[TBL] [Abstract][Full Text] [Related]
31. Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?
Poli JG; Paiva G; Freitas F; Mora P; Velarde LGC; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS
Gynecol Oncol; 2021 Sep; 162(3):638-644. PubMed ID: 34266689
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Resection in the Management of High-Risk Gestational Trophoblastic Neoplasia.
Kanis MJ; Lurain JR
Int J Gynecol Cancer; 2016 May; 26(4):796-800. PubMed ID: 26905332
[TBL] [Abstract][Full Text] [Related]
33. Gestational trophoblastic neoplasia and human immunodeficiency virus infection: a 10-year review.
Tayib S; van Wijk L; Denny L
Int J Gynecol Cancer; 2011 Dec; 21(9):1684-91. PubMed ID: 21997172
[TBL] [Abstract][Full Text] [Related]
34. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
Jareemit N; Horowitz NS; Goldstein DP; Berkowitz RS; Elias KM
Gynecol Oncol; 2020 Dec; 159(3):751-757. PubMed ID: 33023756
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia.
Chu MM; Ma Y; Tse KY; Chan KK; Ngan HY
Int J Gynecol Cancer; 2015 Mar; 25(3):498-503. PubMed ID: 25628108
[TBL] [Abstract][Full Text] [Related]
36. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
[TBL] [Abstract][Full Text] [Related]
37. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment.
Yang J; Xiang Y; Wan X; Yang X
Gynecol Oncol; 2006 Nov; 103(2):479-82. PubMed ID: 16631244
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution.
Yu H; Li J; Zhu T; Xue X; Lu X
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():162-166. PubMed ID: 32505789
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy.
Gadducci A; Cosio S; Fanucchi A; Tana R; Manacorda S; Pistolesi S; Strigini FL
Anticancer Res; 2016 Jul; 36(7):3477-82. PubMed ID: 27354611
[TBL] [Abstract][Full Text] [Related]
40. The efficacy evaluation of initial chemotherapy for high-risk gestational trophoblastic neoplasm.
Li Y; Chen D; Yu H; Xia R; Zhang X; Zheng W
Curr Probl Cancer; 2022 Jun; 46(3):100861. PubMed ID: 35421635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
